Biopharma layoffs are leaving the industry’s scientists reeling — and in search of scarce opportunities

Taking stock of the drug industry, from the lab to the medicine chest

July 10, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Biopharma layoffs are leaving the industry's scientists reeling — and in search of scarce opportunities About 67% of life science employees laid off during the first half of 2024 were at companies with more than $1 billion in annual sales, according to BIO. By Jonathan Wosen STAT+ | VC Flagship Pioneering raises $3.6 billion in new funds The VC firm said it plans to use the funding to develop around 25 new companies focused on human health, sustainability, and artificial intelligence, By Allison DeAngelis Opinion: Listen: Anthony Fauci on presidents, bird flu, and turning down a multimillion-dollar job Dr. Anthony Fauci sits down with STAT to discuss politics, bird flu, turning down a million-dollar job — and keeping a secret while having dinner with Bono. By Rick Berke and Helen Branswell

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser